logo
  

U.S. Construction Spending Unexpectedly Edges Down 0.1% In May

construction spending 070122 lt

Reflecting a decrease in spending on public construction, the Commerce Department released a report on Friday showing an unexpected dip in U.S. construction spending in the month of May.

The report showed construction spending edged down by 0.1 percent to an annual rate of $1.780 trillion in May after climbing by 0.8 percent to an upwardly revised rate of $1.783 trillion in April.

The modest decrease came as a surprise to economists, who had expected construction spending to rise by 0.4 percent compared to the 0.2 percent uptick originally reported for the previous month.

The slight pullback in construction spending came as spending on public construction slid by 0.8 percent to an annual rate of $343.8 billion.

Spending on educational construction fell by 0.4 percent to an annual rate of $78.4 billion, while spending on highway construction tumbled by 2.3 percent to an annual rate of $98.1 billion.

Meanwhile, the Commerce Department said spending on private construction came in at an annual rate of $1.436 trillion in May, virtually unchanged from the previous month.

While spending on residential construction edged up by 0.2 percent to an annual rate of $938.2 billion, spending on non-residential construction decreased by 0.4 percent to an annual rate of $497.8 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT